Hagen Ibsen (lilyjumbo0)

This study investigated the dietary effects of Moringa oleifera leaves supplementation on egg quality, laying performance, excreta ammonia concentrations and serum biochemistry of laying chickens during the late laying period. A total of 240 64-week-old Hy-Line Brown hens were assigned to four treatment diets including Moringa oleifera leaves at 0, 3, 6 or 9 g/kg, respectively, for eight weeks. The treatments had twelve replicates with five hens each. The results revealed that incremental dietary Moringa oleifera leaves significantly increased (p less then 0.01) egg weight, production, and mass through 64-68, 68-72 and 64-72 weeks of age. Simultaneously, feed conversion ratio was significantly improved (p less then 0.01) with Moringa oleifera leaves supplementation compared with the control. Haugh units and the thickness of eggshells significantly improved as a response to diets supplemented with 3, 6 and 9 g/kg Moringa oleifera leaves at 72 weeks of age. Interestingly, excreta ammonia concentrations, serum cholesterol, aspartate transaminase and alanine aminotransferase significantly decreased by Moringa oleifera leaves supplementation compared with the control group. In conclusion, introducing Moringa oleifera leaves supplementation at 3, 6 and 9 g/kg increased egg production, eggshell quality, Haugh units, and decreased serum cholesterol, triglycerides, excreta ammonia concentrations besides serum liver enzymes, uric acid and creatinine. Overall, based on the observed results, Moringa oleifera leaves supplementation was very promising and these leaves could be used as an effective feed additive in laying hens' diet during the late laying period.Rheumatoid arthritis (RA) is an autoimmune disorder affecting a vast variety of the population. The onset of RA as well as the development of systematic immunization is affected by both genetic and environmental risk factors. This review aims to point out the role of natural products in the management of RA, focusing on the reports of basic research (in vitro and animal studies) emphasizing the antioxidant and anti-inflammatory properties considered in the field of RA. A systematic screening of the relevant literature was carried out on PubMed, Google Scholar, and Scopus with the following criteria publication date, 2015-2020; language, English; study design, in vitro or animal models; and the investigation of one or several natural products in the context of RA, including, when available, the molecular mechanisms implicated. A total of 211 papers were initially obtained and screened. In vitro and animal studies referring to 20 natural products and 15 pure compounds were ultimately included in this review. The outcomes of this work provide an overview of the methods employed in basic research over the past five years, with emphasis on the limitations presented, while demonstrating the potential benefits of utilizing natural products in the management of RA as supported by in vitro and animal studies.The COVID-19 pandemic has led to over 2.26 million deaths for almost 104 million confirmed cases worldwide, as of 4 February 2021 (WHO). Selleckchem TDI-011536 Risk factors include pre-existing conditions such as cancer, cardiovascular disease, diabetes, and obesity. Although several vaccines have been deployed, there are few alternative anti-viral treatments available in the case of reduced or non-existent vaccine protection. Adopting a long-term holistic approach to cope with the COVID-19 pandemic appears critical with the emergence of novel and more infectious SARS-CoV-2 variants. Our objective was to identify comorbidity-associated single nucleotide polymorphisms (SNPs), potentially conferring increased susceptibility to SARS-CoV-2 infection using a computational meta-analysis approach. SNP datasets were downloaded from a publicly available genome-wide association studies (GWAS) catalog for 141 of 258 candidate COVID-19 comorbidities. Gene-level SNP analysis was performed to ident